• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Infectious Disease

International study describes characteristics of multisystem inflammatory syndrome in children (MIS-C)

byGabriel ApfelandAlex Gipsman, MD
December 6, 2020
in Infectious Disease, Pediatrics
Reading Time: 2 mins read
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Share on FacebookShare on TwitterShare on LinkedIn

1. Presentation with shock in the setting of multisystem inflammatory syndrome in children (MIS-C) was associated with worse outcomes

2. Shorter duration of MIS-C symptoms prior to hospital admission was associated with poor outcomes

Evidence Rating Level: 2 (Good)

Study Rundown: MIS-C is a complication of SARS-CoV-2 that has led to severe illness in children worldwide, often resulting in shock and multi-organ failure. Despite broad reporting of MIS-C, there has yet to be an international study of this entity. This international cohort of children describes the presentation and clinical course of MIS-C, and identifies clinical and biological predictors of severe disease. Around 40% of patients with MIS-C presented with shock requiring intensive care. Shock was associated with worse outcomes including ECMO and death, especially when the time interval between symptom onset and hospital admission was shorter. Shock was also associated with black race, lower platelet count, and higher inflammatory markers. Data from this large and diverse study can help inform future management of these patients as the pandemic evolves.

Click to read the study in Pediatrics

Relevant Reading: Multi-system Inflammatory Syndrome in US children and adolescents

RELATED REPORTS

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

Adjunctive prednisolone does not reduce coronary artery lesions in Kawasaki disease

FDA approvedFor SARS-CoV-2: Xocova (ensitrelvir), May 29, 2026→

In-Depth [retrospective cohort]: 183 patients from over 30 hospitals in 13 different countries were included in the study. All 183 patients presented with fever and 63.9% presented with gastrointestinal symptoms. 62.3% had evidence of current or recent SARS-CoV-2 infection. Patients were separated into three separate groups depending on their presentation; Kawasaki-like disease (KD) (14.8%), incomplete KD (42.6%), and shock (42.6%). Patients who presented with shock were more likely to be older (9.2  vs 3.8 years in KD-like group and 5.9 in the incomplete KD-like group, p<0.001). Shock was also associated with black race, higher rates of gastrointestinal, cardiorespiratory, and neurological symptoms, significantly lower platelet count, and higher inflammatory markers than the other two groups. These patients also developed more cardiac complications. Patients with KD-like illness required less intensive care and had shorter hospital stays (7.3 days vs. 8.1 in incomplete KD-like, and 9.5 in the shock group, p<0.001) Patients with incomplete KD-like illness were more likely to have better outcomes. A shorter duration of symptoms prior to admission was associated with worse clinical outcomes including death and ECMO requirement. Three patients in the cohort died.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: CoronavirusKawasaki diseasemultisystem inflammatory syndrome in children (MIS-C)SARS-CoV-2
Previous Post

Decline in MMR vaccination rate during the COVID-19 pandemic

Next Post

Masks for personal protection for SARS-CoV-2 infection

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China
Infectious Disease

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

May 26, 2026
Kawasaki disease collage: an engraved heart with its coronary arteries traced in teal beside a plush rabbit with floppy ears
Cardiology

Adjunctive prednisolone does not reduce coronary artery lesions in Kawasaki disease

April 15, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Fall boosters, mosquitoes, skin awareness, and Hollywood healing

August 28, 2025
Kidney disease collage: a pair of engraved kidneys above three smooth gray pebbles and a teal water droplet
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
Next Post

Masks for personal protection for SARS-CoV-2 infection

Success rates and timelines of recently studied viral vaccine candidates

Medical home linked to lower pediatric readmission rate

2 Minute Medicine Rewind December 7, 2020

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cannabis use, including smoked or edible, linked to higher stroke risk
  • Ivonescimab plus chemotherapy produced major and complete pathological responses in resectable NSCLC in a phase II study
  • Subcutaneous amivantamab received accelerated approval for recurrent or metastatic head and neck cancer after platinum chemotherapy and immunotherapy
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.